AzurRx BioPharma

$1.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-11.11%) As of 7:30 PM UTC today

Why Robinhood?

You can buy or sell AZRX and other stocks, options, and ETFs commission-free!

About AZRX

AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. The company was founded on January 30, 2014 and is headquartered in Delray Beach, FL. The listed name for AZRX is AzurRx BioPharma, Inc. Common Stock.

CEO

James E. Sapirstein

Employees

Headquarters

Delray Beach, Florida

Founded

2014

Market Cap

64.20M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.13M

High Today

$1.29

Low Today

$1.13

Open Price

$1.25

Volume

2.33M

52 Week High

$2.63

52 Week Low

$0.3709

AZRX Earnings

-$0.46

-$0.31

-$0.15

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 29, After Hours